|
JP5435592B2
(ja)
|
2008-05-28 |
2014-03-05 |
ファイザー・インク |
ピラゾロスピロケトンアセチルＣｏＡカルボキシラーゼ阻害剤
|
|
UA102336C2
(uk)
*
|
2009-11-10 |
2013-06-25 |
Пфайзер Інк. |
N1-ПІРАЗОЛСПІРОКЕТОНИ ЯК ІНГІБІТОРИ АЦЕТИЛ-СоА-КАРБОКСИЛАЗ
|
|
ES2557895T3
(es)
|
2010-03-19 |
2016-01-29 |
Pfizer Inc |
Derivados de 2,3-dihidro-1H-inden-1-il-2,7-diazaespiro[3.6]nonano y su uso como antagonistas o agonistas inversos del receptor de grelina
|
|
US9006450B2
(en)
*
|
2010-07-01 |
2015-04-14 |
Boehringer Ingelheim International Gmbh |
Compounds, pharmaceutical compositions and uses thereof
|
|
DK2621493T3
(en)
|
2010-09-30 |
2016-10-24 |
Pfizer |
N1 PYRAZOLOSPIROKETON-ACETYL-CoA carboxylase INHIBITORS
|
|
CN103189377B
(zh)
*
|
2010-10-29 |
2015-02-25 |
辉瑞大药厂 |
N1/n2-内酰胺乙酰辅酶a羧化酶抑制剂
|
|
EA022375B1
(ru)
|
2011-04-22 |
2015-12-30 |
Пфайзер Инк. |
ПРОИЗВОДНЫЕ ПИРАЗОЛОСПИРОКЕТОНОВ ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ АЦЕТИЛ-КоА-КАРБОКСИЛАЗ
|
|
JP2014520879A
(ja)
|
2011-07-15 |
2014-08-25 |
ファイザー・インク |
Ｇｐｒ１１９調節因子
|
|
RU2013157388A
(ru)
|
2011-07-22 |
2015-08-27 |
Пфайзер Инк. |
Хинолинильные модуляторы глюкагонового рецептора
|
|
WO2013030713A1
(en)
|
2011-08-31 |
2013-03-07 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3] thiazin-2-amine compounds
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
AU2012335220B2
(en)
|
2011-11-11 |
2017-06-01 |
Pfizer Inc. |
2-thiopyrimidinones
|
|
AU2013245353A1
(en)
|
2012-04-06 |
2014-09-25 |
Pfizer Inc. |
Diacylglycerol acyltransferase 2 inhibitors
|
|
US8889730B2
(en)
|
2012-04-10 |
2014-11-18 |
Pfizer Inc. |
Indole and indazole compounds that activate AMPK
|
|
WO2013164730A1
(en)
|
2012-05-04 |
2013-11-07 |
Pfizer Inc. |
Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin- 2 -amine compounds as inhibitors of app, bace1 and bace 2.
|
|
JP2015529239A
(ja)
|
2012-09-20 |
2015-10-05 |
ファイザー・インク |
アルキル置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
CA2893256A1
(en)
|
2012-12-11 |
2014-06-19 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
|
|
CA2893333C
(en)
|
2012-12-19 |
2017-10-24 |
Pfizer Inc. |
Carbocyclic-and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
WO2014125394A1
(en)
|
2013-02-13 |
2014-08-21 |
Pfizer Inc. |
HETEROARYL-SUBSTITUTED HEXAHYDROPYRANO [3,4-d][1,3] THIAZIN-2-AMINE COMPOUNDS
|
|
US9233981B1
(en)
|
2013-02-15 |
2016-01-12 |
Pfizer Inc. |
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
MX2016002479A
(es)
|
2013-09-12 |
2016-05-31 |
Pfizer |
Uso de inhibidores de acetil-coa carboxilasa para tratar acne vulgaris.
|
|
ES2665153T3
(es)
|
2013-10-09 |
2018-04-24 |
Pfizer Inc. |
Antagonistas del receptor EP3 de prostaglandina
|
|
CU24395B1
(es)
|
2014-03-17 |
2019-04-04 |
Pfizer |
Inhibidores de diacilglicerol aciltransferasa 2
|
|
PL3536685T3
(pl)
|
2014-04-04 |
2022-05-16 |
Pfizer Inc. |
Bicykliczne skondensowane związki heteroarylowe lub arylowe i ich zastosowanie jako inhibitory IRAK4
|
|
JP6111002B1
(ja)
|
2014-04-10 |
2017-04-05 |
ファイザー・インク |
２−アミノ−６−メチル−４，４ａ，５，６−テトラヒドロピラノ［３，４−ｄ］［１，３］チアジン−８ａ（８Ｈ）−イル−１，３−チアゾール−４−イルアミド
|
|
EP3194367B1
(en)
*
|
2014-09-17 |
2021-08-18 |
Boehringer Ingelheim International GmbH |
Tetrahydroisoquinoline derivatives and pharmaceutical compositions useful for the treatment of obesity and diabetes
|
|
WO2016092413A1
(en)
|
2014-12-10 |
2016-06-16 |
Pfizer Inc. |
Indole and indazole compounds that activate ampk
|
|
EP3237401B1
(en)
|
2014-12-22 |
2019-03-06 |
Pfizer Inc |
Antagonists of prostaglandin ep3 receptor
|
|
SG11201708407TA
(en)
|
2015-05-05 |
2017-11-29 |
Pfizer |
2-thiopyrimidinones
|
|
WO2016193844A1
(en)
|
2015-05-29 |
2016-12-08 |
Pfizer Inc. |
Novel heterocyclic compounds as inhibitors of vanin-1 enzyme
|
|
DK3310784T3
(da)
|
2015-06-17 |
2020-11-09 |
Pfizer |
Tricykliske forbindelser og deres anvendelse som phosphodiesterasehæmmere
|
|
WO2016203335A1
(en)
|
2015-06-18 |
2016-12-22 |
Pfizer Inc. |
Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
|
|
US20180230127A1
(en)
|
2015-08-13 |
2018-08-16 |
Pfizer Inc. |
Bicyclic-Fused Heteroaryl Or Aryl Compounds
|
|
HRP20210472T1
(hr)
|
2015-08-27 |
2021-05-14 |
Pfizer Inc. |
Biciklički kondenzirani heteroarilni ili arilni spojevi kao modulatori irak4
|
|
WO2017037567A1
(en)
|
2015-09-03 |
2017-03-09 |
Pfizer Inc. |
Regulators of frataxin
|
|
WO2017051303A1
(en)
|
2015-09-24 |
2017-03-30 |
Pfizer Inc. |
Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
|
|
EP3353174A1
(en)
|
2015-09-24 |
2018-08-01 |
Pfizer Inc |
N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl]amides useful as bace inhibitors
|
|
JP2018531923A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
Ｎ−［２−（２−アミノ−６，６−二置換−４，４ａ，５，６−テトラヒドロピラノ［３，４−ｄ］［１，３］チアジン−８ａ（８Ｈ）−イル）−１，３−チアゾール−４−イル］アミド
|
|
TN2018000198A1
(en)
|
2015-12-29 |
2019-10-04 |
Pfizer |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
|
|
AU2017252015A1
(en)
|
2016-04-19 |
2018-11-08 |
Ureka Sarl |
Peptide-oligourea foldamer compounds and methods of their use
|
|
US10906888B2
(en)
|
2016-07-14 |
2021-02-02 |
Pfizer Inc. |
Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme
|
|
AR109179A1
(es)
|
2016-08-19 |
2018-11-07 |
Pfizer |
Inhibidores de diacilglicerol aciltransferasa 2
|
|
WO2019133445A1
(en)
|
2017-12-28 |
2019-07-04 |
Inception Ibd, Inc. |
Aminothiazoles as inhibitors of vanin-1
|
|
JP7161605B2
(ja)
|
2018-08-31 |
2022-10-26 |
ファイザー・インク |
Ｎａｓｈ／ｎａｆｌｄおよび関連疾患の治療のための組合せ
|
|
WO2020102575A1
(en)
|
2018-11-16 |
2020-05-22 |
Inception Ibd, Inc. |
Heterocyclic aminothiazoles and uses thereof
|
|
US12479816B2
(en)
|
2019-02-08 |
2025-11-25 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
20-HETE formation inhibitors
|
|
CA3140972C
(en)
|
2019-05-20 |
2024-06-18 |
Pfizer Inc. |
Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
|
|
CN110922372A
(zh)
*
|
2019-11-04 |
2020-03-27 |
天津大学 |
达格列净的氨基酸共晶物及其制备方法
|
|
PT4097099T
(pt)
|
2020-02-07 |
2024-07-19 |
Gasherbrum Bio Inc |
Agonistas heterocíclicos de glp-1
|
|
WO2021219019A1
(en)
|
2020-04-29 |
2021-11-04 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
KR20230013126A
(ko)
*
|
2020-05-21 |
2023-01-26 |
시오노기 앤드 컴파니, 리미티드 |
지방성 간질환의 치료용 의약
|
|
EP4490155A1
(en)
|
2022-03-09 |
2025-01-15 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
US20250250269A1
(en)
|
2022-04-14 |
2025-08-07 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
WO2024118524A1
(en)
|
2022-11-28 |
2024-06-06 |
Cerevel Therapeutics, Llc |
Azaindole compounds and their use as phosphodiesterase inhibitors
|
|
CN121002014A
(zh)
|
2022-12-15 |
2025-11-21 |
加舒布鲁姆生物公司 |
具有glp-1激动剂活性的化合物的盐和固体形式
|